Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR
about
The Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic DiseasesThe effects of microRNA on the absorption, distribution, metabolism and excretion of drugsNoncoding RNAs: key molecules in understanding and treating painmiR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammationMicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivoMicroRNA-management of lipoprotein homeostasis.Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33Development of microRNA therapeutics is coming of age.Epigenetic regulation of cholesterol homeostasis.microRNAs and HDL life cycle.Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in miceMicroRNAs: a connection between cholesterol metabolism and neurodegeneration.Prospects for Therapeutic Targeting of MicroRNAs in Human Immunological Diseases.MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.Inhibition of Gastric Tumor Cell Growth Using Seed-targeting LNA as Specific, Long-lasting MicroRNA Inhibitors.Cooperative target mRNA destabilization and translation inhibition by miR-58 microRNA family in C. elegans.microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the BrainTherapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity.MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosisMicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN.MicroRNA Regulation of Atherosclerosis.SREBP-1c/MicroRNA 33b Genomic Loci Control Adipocyte Differentiation.Micro-RNAs and High-Density Lipoprotein Metabolism.microRNA regulation of lipoprotein metabolism.How Gene Networks Can Uncover Novel CVD Players.microRNAs in lipoprotein metabolism and cardiometabolic disorders.MicroRNAs in heart failure: Non-coding regulators of metabolic function.Relevance of microRNA in metabolic diseases.miRNAs in atherosclerotic plaque initiation, progression, and rupture.miRNA and cholesterol homeostasis.miRNAs and High-Density Lipoprotein metabolism.miRNA regulation of LDL-cholesterol metabolism.microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.Truths and controversies concerning the role of miRNAs in atherosclerosis and lipid metabolism.MicroRNAs and lipid metabolism.Nutriepigenomics and malnutrition.The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophagesNovel Role of miR-33 in Regulating of Mitochondrial Function.
P2860
Q26750496-8003AF17-F750-4D85-8736-4EBF505C87FCQ26822987-76CF7B39-BBC4-4148-BAB7-F9D57AC24552Q26998622-EB1002CC-2041-4768-BE47-FF47973F39E8Q33556109-E917A1AB-990B-44C8-813E-934A017A9D52Q33760162-E3652E33-13E9-43F2-BA10-17AFFE09C8B9Q33851062-9B55363E-1BFF-4D55-BB40-3D72098DF1A9Q33896588-67566968-4FA0-482F-ACE7-6A50F1378A50Q33940346-88CBBD0E-E332-4C4B-AE75-80EB60ECF046Q33991443-8ADBDA7E-E4FA-4AE2-9247-2331E6A1D038Q34238886-BE078455-DD47-4335-83B1-D8C6E1BDB4BBQ34248289-1CB986B8-4CB2-4B5A-A663-E8EFDF5FABCEQ34342477-1E707788-513D-4E88-97C8-561299E4414BQ34613640-7EF5129F-2B87-40D3-AFAF-61D8B58C20EFQ35619546-3FE5B4F2-F3E0-4EEF-8F4F-F3DE3FFDA522Q35836093-7FAB82CA-9CC4-4B14-AD26-64634163CD88Q36033063-254FFCEB-08E9-4EC3-8CAD-AE17388AED6DQ36199571-C1EB63E4-4062-462A-BC49-AF74D9B20483Q36254032-70273420-0949-4293-BEEE-BD2A643544CDQ36326825-12E0A300-2EE6-4097-9A6A-0B88CEF0991EQ36335947-F8B72C2A-6451-4C3F-BC68-C9896EB3B1C5Q36459815-3E039FFA-A505-4613-8BED-024189FBC8ECQ36536455-9DA039DB-A736-4E18-8330-E85C36255561Q36602813-FEB5FD93-1CCB-4C78-B06F-C165414632A5Q36709238-88BB1778-3CA0-4E29-A7A7-98A12724FCE5Q37650114-66C4FE75-730E-4A45-B841-50168750155EQ37650119-768FDBAD-9225-4F6A-9D1D-BFEF3B487028Q37664007-7EC78E95-F1A6-433A-ACDE-B56E55D46E4AQ37709886-72C45DEE-8E5B-4CD4-8CFE-5B2BB20AC957Q37733659-6ADF4904-988C-44DB-A8F8-AF7D5265F55CQ38230799-3D5160C2-F99B-4D76-9B3C-4EBED414820CQ38377790-6FF015C7-8796-4A3E-92DD-F5857525958AQ38700512-5788C10A-0180-4842-BECC-CF5159E2FF38Q38730644-7D07E39F-74B7-49C4-A77E-77D76F68C036Q38770213-5D0EB1CE-3FBF-4D1D-9B5B-79110103DAD1Q38827780-8B1A2CC7-107B-400A-8C83-96839502651CQ38984142-23A158B6-86A4-4D3B-8A60-EE7A5BFC3FBBQ39195873-FF5C2841-D756-424D-B831-46B73958DE3EQ39344386-BA36166A-D13B-4443-8765-02B0779235F7Q41308451-DC367123-17D1-45E1-9402-1835D09874ADQ43177860-3A6FA867-F50E-4F33-8335-3FAE9311D6BA
P2860
Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmacological inhibition of ...... a seed-targeting 8-mer antimiR
@ast
Pharmacological inhibition of ...... a seed-targeting 8-mer antimiR
@en
type
label
Pharmacological inhibition of ...... a seed-targeting 8-mer antimiR
@ast
Pharmacological inhibition of ...... a seed-targeting 8-mer antimiR
@en
prefLabel
Pharmacological inhibition of ...... a seed-targeting 8-mer antimiR
@ast
Pharmacological inhibition of ...... a seed-targeting 8-mer antimiR
@en
P2093
P2860
P1476
Pharmacological inhibition of ...... a seed-targeting 8-mer antimiR
@en
P2093
Anders M Näär
Andreas Petri
Andrew S deLemos
Henrik F Hansen
Johnathan R Whetstine
Joshua C Black
Matthew S Lawrence
Raymond T Chung
Robert E Gerszten
Robert McGarrah
P2860
P304
P356
10.1126/SCITRANSLMED.3006840
P407
P577
2013-11-01T00:00:00Z